Alto Neuroscience (ANRO) Return on Assets (2024 - 2026)

Alto Neuroscience (ANRO) reported Return on Assets of 0.1% for Q1 2026, down 10.0% on a YoY basis from 0.11% in Q1 2025, and up 27.71% sequentially from 0.14% in Q4 2025.

Alto Neuroscience (ANRO) Return on Assets (2024 - 2026) Analysis & Trends

Alto Neuroscience (ANRO) has 3 years of Return on Assets data on file, last reported at 0.1% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Assets fell 10.0% year-over-year to 0.1%; the trailing twelve-month figure through Mar 2026 stood at 0.1% (down 10.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
  • Return on Assets grew to 0.1% in Q1 2026, from 0.14% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2024 to a low of 0.15% in Q3 2025.
  • A 3-year average of 0.05% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
  • Peak annual rise in Return on Assets reached 0 bps in 2025, while the deepest fall reached 15 bps in 2025.
  • Tracing ANRO's Return on Assets over 3 years: stood at 0.0% in 2024, then tumbled by 4018 bps to 0.14% in 2025, then advanced by 28 bps to 0.1% in 2026.
  • Business Quant data shows ANRO's Return on Assets at 0.1% in Q1 2026, 0.14% in Q4 2025, and 0.15% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -0.69%
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -0.01%
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.00%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.00%
7 Belite Bio 61.40 Bn 61.40 Bn - -0.80%
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 0.00%
10 Alto Neuroscience 869.36 Mn 869.36 Mn - -0.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.10%
Dec 31, 2025 -0.14%
Sep 30, 2025 -0.15%
Jun 30, 2025 -0.03%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%